Akums Drugs

{
  "main_header": {
    "sid": 10039335,
    "name": "Akums Drugs",
    "stock_name": "Akums Drugs",
    "full_name": "Akums Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/akums-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "428.00",
    "chg": -0.75,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "428.75",
    "mcapval": "6,736.46 Cr",
    "mcap": "Small Cap",
    "scripcode": "544222",
    "symbol": "AKUMS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE09XN01023",
    "curr_date": "Jan 28",
    "curr_time": "",
    "bse_nse_vol": "16.15 k",
    "exc_status": "Active",
    "traded_date": "Jan 28, 2026",
    "traded_date_str": "2026 01 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-faces-technical-momentum-shift-amid-bearish-signals-3805033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AkumsDrugsPharm_technicaldot_3805033.png",
        "date": "2026-01-27 08:03:44",
        "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains cautious, reflecting the stock’s underperformance relative to the broader market and sector benchmarks."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3798128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AkumsDrugsPharm_mojoScore_3798128.png",
        "date": "2026-01-21 10:10:53",
        "description": "Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 January 2026, providing investors with the latest view of the stock’s position."
      },
      {
        "title": "Why is Akums Drugs & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-akums-drugs-pharmaceuticals-ltd-fallingrising-3797485",
        "imagepath": "",
        "date": "2026-01-21 01:36:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been on a downward trajectory, falling nearly 4.83% over the past week, significantly underperforming the Sensex, which declined by 1.73% in the same period. Year-to-date, Akums Drugs has lost 6.99%, almost double the Sensex's 3.57% decline. Over the last year, the stock has plummeted by 32.70%, contrasting sharply with the Sensex's 6.63% gain. This sustained underperformance highlights investor concerns about the company’s prospects.</p>\n<p>On the day in question, the stock traded close to its 52-week low, just 3.46% above the bottom price of ₹407.4. Intraday, it touched a low of ₹420.05, reflecting persistent selling pressure. The weighted average price indicates that more volume was traded near the lower end of the day..."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3787953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AkumsDrugsPharm_mojoScore_3787953.png",
        "date": "2026-01-10 10:10:49",
        "description": "Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3774754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AkumsDrugsPharm_mojoScore_3774754.png",
        "date": "2025-12-30 10:10:31",
        "description": "Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 30 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Akums Drugs & Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-technical-momentum-shifts-amid-mixed-market-signals-3766584",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AkumsDrugsPharm_technicaldot_3766584.png",
        "date": "2025-12-23 08:18:58",
        "description": "Akums Drugs & Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent price movements and technical parameters suggest a transition from a mildly bearish stance to a more sideways trend, highlighting a period of consolidation amid fluctuating investor sentiment."
      },
      {
        "title": "Akums Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-downgraded-to-strong-sell-amid-weak-fundamentals-and-negative-financial-trends-3763713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AkumsDrugs_mojoScore_3763713.png",
        "date": "2025-12-19 10:10:20",
        "description": "Akums Drugs has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. The pharmaceutical company’s recent assessment highlights a complex interplay of valuation appeal, financial pressures, and technical signals, set against a backdrop of subdued sector performance and market capitalisation constraints."
      },
      {
        "title": "Akums Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-downgraded-to-strong-sell-amid-weak-fundamentals-and-negative-financial-trends-3735195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AkumsDrugs_mojoScore_3735195.png",
        "date": "2025-11-28 10:05:12",
        "description": "Akums Drugs has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor sentiment and market positioning. This adjustment highlights evolving perspectives on the company’s financial health, valuation, technical outlook, and overall quality within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "How has been the historical performance of Akums Drugs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-akums-drugs-3709302",
        "imagepath": "",
        "date": "2025-11-17 23:27:20",
        "description": "Answer:\nThe historical performance of Akums Drugs shows a significant recovery and growth in recent years, particularly in the fiscal year ending March 2025.\n\nBreakdown:\nIn the fiscal year ending March 2025, Akums Drugs reported net sales of 4,118.16 crore, slightly down from 4,178.18 crore in March 2024 but up from 3,654.82 crore in March 2023. The total operating income mirrored the net sales at 4,118.16 crore for March 2025. The company's total expenditure decreased to 3,653.67 crore in March 2025 from 4,055.20 crore in March 2024, contributing to an operating profit (PBDIT) of 516.61 crore, a substantial increase from 157.01 crore in the previous year. Profit before tax turned positive at 345.25 crore in March 2025, recovering from a loss of 45.28 crore in March 2024, while profit after tax surged to 343.78 crore compared to just 0.79 crore in the prior year. The consolidated net profit also reflected t..."
      }
    ],
    "total": 154,
    "sid": "10039335",
    "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Akums Drugs & Pharmaceuticals Ltd Faces Technical Momentum Shift Amid Bearish Signals

2026-01-27 08:03:44

Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains cautious, reflecting the stock’s underperformance relative to the broader market and sector benchmarks.

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-01-21 10:10:53

Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 January 2026, providing investors with the latest view of the stock’s position.

Read full news article

Why is Akums Drugs & Pharmaceuticals Ltd falling/rising?

2026-01-21 01:36:29

Recent Price Movement and Market Context

The stock has been on a downward trajectory, falling nearly 4.83% over the past week, significantly underperforming the Sensex, which declined by 1.73% in the same period. Year-to-date, Akums Drugs has lost 6.99%, almost double the Sensex's 3.57% decline. Over the last year, the stock has plummeted by 32.70%, contrasting sharply with the Sensex's 6.63% gain. This sustained underperformance highlights investor concerns about the company’s prospects.

On the day in question, the stock traded close to its 52-week low, just 3.46% above the bottom price of ₹407.4. Intraday, it touched a low of ₹420.05, reflecting persistent selling pressure. The weighted average price indicates that more volume was traded near the lower end of the day...

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-01-10 10:10:49

Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2025-12-30 10:10:31

Akums Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 30 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Akums Drugs & Pharmaceuticals: Technical Momentum Shifts Amid Mixed Market Signals

2025-12-23 08:18:58

Akums Drugs & Pharmaceuticals has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and indicator signals. Recent price movements and technical parameters suggest a transition from a mildly bearish stance to a more sideways trend, highlighting a period of consolidation amid fluctuating investor sentiment.

Read full news article

Akums Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-19 10:10:20

Akums Drugs has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. The pharmaceutical company’s recent assessment highlights a complex interplay of valuation appeal, financial pressures, and technical signals, set against a backdrop of subdued sector performance and market capitalisation constraints.

Read full news article

Akums Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-11-28 10:05:12

Akums Drugs has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor sentiment and market positioning. This adjustment highlights evolving perspectives on the company’s financial health, valuation, technical outlook, and overall quality within the Pharmaceuticals & Biotechnology sector.

Read full news article

How has been the historical performance of Akums Drugs?

2025-11-17 23:27:20

Answer: The historical performance of Akums Drugs shows a significant recovery and growth in recent years, particularly in the fiscal year ending March 2025. Breakdown: In the fiscal year ending March 2025, Akums Drugs reported net sales of 4,118.16 crore, slightly down from 4,178.18 crore in March 2024 but up from 3,654.82 crore in March 2023. The total operating income mirrored the net sales at 4,118.16 crore for March 2025. The company's total expenditure decreased to 3,653.67 crore in March 2025 from 4,055.20 crore in March 2024, contributing to an operating profit (PBDIT) of 516.61 crore, a substantial increase from 157.01 crore in the previous year. Profit before tax turned positive at 345.25 crore in March 2025, recovering from a loss of 45.28 crore in March 2024, while profit after tax surged to 343.78 crore compared to just 0.79 crore in the prior year. The consolidated net profit also reflected t...

Read full news article

View All News